Cognitive impairments in humans with multiple sclerosis are treated and cognition is improved with an amphetamine compound. In one embodiment, the method includes administering an l-amphetamine compound. In another embodiment, the method includes administering an l-methamphetamine compound.

 
Web www.patentalert.com

< Fibroblast growth factor-like polypeptides and variants thereof

> PRO214 polypeptides

> Methods and apparatus for treatment of obesity

~ 00559